Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the xCELLigence System for Quantification of Bacterial Biofilm's Real Time Formation and Antibiotics Selection: Randomized Clinical Trial.

NCT03863249 is registered in ClinicalTrials.gov with University of Valencia as lead sponsor.

NCT NCT03863249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03863249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the xCELLigence System for Quantification of Bacterial Biofilm's Real Time Formation and Antibiotics Selection: Randomized Clinical Trial.
Lead sponsor
University of Valencia
Phase
Phase 4
Overall status
Completed
Start date
February 8, 2019
Completion date
May 30, 2022
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic periodontitis, periodontal bone loss, resistance bacterial